Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 589 to 594 of 594 entries
Sorted by: Best Match Show Resources per page
The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial.

Journal of medical Internet research

Trojan A, Leuthold N, Thomssen C, Rody A, Winder T, Jakob A, Egger C, Held U, Jackisch C.
PMID: 34383675
J Med Internet Res. 2021 Aug 05;23(8):e29271. doi: 10.2196/29271.

BACKGROUND: Electronic patient-reported outcomes (ePRO) are a relatively novel form of data and have the potential to improve clinical practice for cancer patients. In this prospective, multicenter, observational clinical trial, efforts were made to demonstrate the reliability of patient-reported...

Cite
Trojan A, Leuthold N, Thomssen C, et al. The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial. J Med Internet Res. 2021;23(8):e29271doi: 10.2196/29271.
Trojan, A., Leuthold, N., Thomssen, C., Rody, A., Winder, T., Jakob, A., Egger, C., Held, U., & Jackisch, C. (2021). The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial. Journal of medical Internet research, 23(8), e29271. https://doi.org/10.2196/29271
Trojan, Andreas, et al. "The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial." Journal of medical Internet research vol. 23,8 (2021): e29271. doi: https://doi.org/10.2196/29271
Trojan A, Leuthold N, Thomssen C, Rody A, Winder T, Jakob A, Egger C, Held U, Jackisch C. The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial. J Med Internet Res. 2021 Aug 05;23(8):e29271. doi: 10.2196/29271. PMID: 34383675; PMCID: PMC8380582.
Copy Download .nbib Format: NLM
Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course.

The oncologist

Vogt J, Beyer F, Sistermanns J, Kuon J, Kahl C, Alt-Epping B, Stevens S, Ahlborn M, George C, Heider A, Tienken M, Loquai C, Stahlhut K, Ruellan A, Kubin T, Dietz A, Oechsle K, Mehnert-Theuerkauf A, van Oorschot B, Thomas M, Ortmann O, Engel C, Lordick F.
PMID: 33687742
Oncologist. 2021 Jun;26(6):e1058-e1065. doi: 10.1002/onco.13751. Epub 2021 Mar 30.

BACKGROUND: Although current guidelines advocate early integration of palliative care, symptom burden and palliative care needs of patients at diagnosis of incurable cancer and along the disease trajectory are understudied.MATERIAL AND METHODS: We assessed distress, symptom burden, quality of...

Cite
Vogt J, Beyer F, Sistermanns J, et al. Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course. Oncologist. 2021;26(6):e1058-e1065doi: 10.1002/onco.13751.
Vogt, J., Beyer, F., Sistermanns, J., Kuon, J., Kahl, C., Alt-Epping, B., Stevens, S., Ahlborn, M., George, C., Heider, A., Tienken, M., Loquai, C., Stahlhut, K., Ruellan, A., Kubin, T., Dietz, A., Oechsle, K., Mehnert-Theuerkauf, A., van Oorschot, B., Thomas, M., Ortmann, O., Engel, C., Lordick, F. (2021). Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course. The oncologist, 26(6), e1058-e1065. https://doi.org/10.1002/onco.13751
Vogt, Jeannette, et al. "Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course." The oncologist vol. 26,6 (2021): e1058-e1065. doi: https://doi.org/10.1002/onco.13751
Vogt J, Beyer F, Sistermanns J, Kuon J, Kahl C, Alt-Epping B, Stevens S, Ahlborn M, George C, Heider A, Tienken M, Loquai C, Stahlhut K, Ruellan A, Kubin T, Dietz A, Oechsle K, Mehnert-Theuerkauf A, van Oorschot B, Thomas M, Ortmann O, Engel C, Lordick F. Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course. Oncologist. 2021 Jun;26(6):e1058-e1065. doi: 10.1002/onco.13751. Epub 2021 Mar 30. PMID: 33687742; PMCID: PMC8176980.
Copy Download .nbib Format: NLM
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.

Lancet (London, England)

Xu B, Tu S, Song L, Jin Z, Yu B, Fu G, Zhou Y, Wang J, Chen Y, Pu J, Chen L, Qu X, Yang J, Liu X, Guo L, Shen C, Zhang Y, Zhang Q, Pan H, Fu X, Liu J, Zhao Y, Escaned J, Wang Y, Fearon WF, Dou K, Kirtane AJ, Wu Y, Serruys PW, Yang W, Wijns W, Guan C, Leon MB, Qiao S, Stone GW.
PMID: 34742368
Lancet. 2021 Dec 11;398(10317):2149-2159. doi: 10.1016/S0140-6736(21)02248-0. Epub 2021 Nov 04.

BACKGROUND: Compared with visual angiographic assessment, pressure wire-based physiological measurement more accurately identifies flow-limiting lesions in patients with coronary artery disease. Nonetheless, angiography remains the most widely used method to guide percutaneous coronary intervention (PCI). In FAVOR III China,...

Cite
Xu B, Tu S, Song L, et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet. 2021;398(10317):2149-2159doi: 10.1016/S0140-6736(21)02248-0.
Xu, B., Tu, S., Song, L., Jin, Z., Yu, B., Fu, G., Zhou, Y., Wang, J., Chen, Y., Pu, J., Chen, L., Qu, X., Yang, J., Liu, X., Guo, L., Shen, C., Zhang, Y., Zhang, Q., Pan, H., Fu, X., Liu, J., Zhao, Y., Escaned, J., Wang, Y., Fearon, W. F., Dou, K., Kirtane, A. J., Wu, Y., Serruys, P. W., Yang, W., Wijns, W., Guan, C., Leon, M. B., Qiao, S., Stone, G. W. (2021). Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet (London, England), 398(10317), 2149-2159. https://doi.org/10.1016/S0140-6736(21)02248-0
Xu, Bo, et al. "Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial." Lancet (London, England) vol. 398,10317 (2021): 2149-2159. doi: https://doi.org/10.1016/S0140-6736(21)02248-0
Xu B, Tu S, Song L, Jin Z, Yu B, Fu G, Zhou Y, Wang J, Chen Y, Pu J, Chen L, Qu X, Yang J, Liu X, Guo L, Shen C, Zhang Y, Zhang Q, Pan H, Fu X, Liu J, Zhao Y, Escaned J, Wang Y, Fearon WF, Dou K, Kirtane AJ, Wu Y, Serruys PW, Yang W, Wijns W, Guan C, Leon MB, Qiao S, Stone GW. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet. 2021 Dec 11;398(10317):2149-2159. doi: 10.1016/S0140-6736(21)02248-0. Epub 2021 Nov 04. PMID: 34742368.
Copy Download .nbib Format: NLM
Teaching Medical Students to Help Patients Manage Their Weight: Outcomes of an Eight-School Randomized Controlled Trial.

Journal of general internal medicine

Ockene JK, Pbert L, Crawford S, Frisard CF, Pendharkar JA, Sadasivam RS, Faro J, Okuliar C, Eno C, Margo K, Shaw MA, Soleymani T, Stadler DD, Warrier S, White K, Geller AC.
PMID: 33835315
J Gen Intern Med. 2021 Oct;36(10):3000-3007. doi: 10.1007/s11606-020-06571-x. Epub 2021 Apr 09.

BACKGROUND: Given the rising rates of obesity there is a pressing need for medical schools to better prepare students for intervening with patients who have overweight or obesity and for prevention efforts.OBJECTIVE: To assess the effect of a multi-modal...

Cite
Ockene JK, Pbert L, Crawford S, et al. Teaching Medical Students to Help Patients Manage Their Weight: Outcomes of an Eight-School Randomized Controlled Trial. J Gen Intern Med. 2021;36(10):3000-3007doi: 10.1007/s11606-020-06571-x.
Ockene, J. K., Pbert, L., Crawford, S., Frisard, C. F., Pendharkar, J. A., Sadasivam, R. S., Faro, J., Okuliar, C., Eno, C., Margo, K., Shaw, M. A., Soleymani, T., Stadler, D. D., Warrier, S., White, K., & Geller, A. C. (2021). Teaching Medical Students to Help Patients Manage Their Weight: Outcomes of an Eight-School Randomized Controlled Trial. Journal of general internal medicine, 36(10), 3000-3007. https://doi.org/10.1007/s11606-020-06571-x
Ockene, Judith K, et al. "Teaching Medical Students to Help Patients Manage Their Weight: Outcomes of an Eight-School Randomized Controlled Trial." Journal of general internal medicine vol. 36,10 (2021): 3000-3007. doi: https://doi.org/10.1007/s11606-020-06571-x
Ockene JK, Pbert L, Crawford S, Frisard CF, Pendharkar JA, Sadasivam RS, Faro J, Okuliar C, Eno C, Margo K, Shaw MA, Soleymani T, Stadler DD, Warrier S, White K, Geller AC. Teaching Medical Students to Help Patients Manage Their Weight: Outcomes of an Eight-School Randomized Controlled Trial. J Gen Intern Med. 2021 Oct;36(10):3000-3007. doi: 10.1007/s11606-020-06571-x. Epub 2021 Apr 09. PMID: 33835315; PMCID: PMC8034040.
Copy Download .nbib Format: NLM
Epidemiology of Pediatric Heart Failure in the USA-a 15-Year Multi-Institutional Study.

Pediatric cardiology

Morales-Demori R, Montañes E, Erkonen G, Chance M, Anders M, Denfield S.
PMID: 33871685
Pediatr Cardiol. 2021 Aug;42(6):1297-1307. doi: 10.1007/s00246-021-02611-3. Epub 2021 Apr 19.

The epidemiology of pediatric heart failure (HF) has been characterized for congenital heart disease (CHD) and cardiomyopathies (CM), but the impact of CM associated with CHD has not been studied. This study aims to describe the characteristics and outcomes...

Cite
Morales-Demori R, Montañes E, Erkonen G, et al. Epidemiology of Pediatric Heart Failure in the USA-a 15-Year Multi-Institutional Study. Pediatr Cardiol. 2021;42(6):1297-1307doi: 10.1007/s00246-021-02611-3.
Morales-Demori, R., Montañes, E., Erkonen, G., Chance, M., Anders, M., & Denfield, S. (2021). Epidemiology of Pediatric Heart Failure in the USA-a 15-Year Multi-Institutional Study. Pediatric cardiology, 42(6), 1297-1307. https://doi.org/10.1007/s00246-021-02611-3
Morales-Demori, Raysa, et al. "Epidemiology of Pediatric Heart Failure in the USA-a 15-Year Multi-Institutional Study." Pediatric cardiology vol. 42,6 (2021): 1297-1307. doi: https://doi.org/10.1007/s00246-021-02611-3
Morales-Demori R, Montañes E, Erkonen G, Chance M, Anders M, Denfield S. Epidemiology of Pediatric Heart Failure in the USA-a 15-Year Multi-Institutional Study. Pediatr Cardiol. 2021 Aug;42(6):1297-1307. doi: 10.1007/s00246-021-02611-3. Epub 2021 Apr 19. PMID: 33871685.
Copy Download .nbib Format: NLM
Is the 1-day surprise question a useful screening tool for predicting prognosis in patients with advanced cancer?-a multicenter prospective observational study.

Annals of palliative medicine

Ikari T, Hiratsuka Y, Yamaguchi T, Mori M, Uneno Y, Taniyama T, Matsuda Y, Oya K, Amano K, Tagami K, Inoue A.
PMID: 34670389
Ann Palliat Med. 2021 Nov;10(11):11278-11287. doi: 10.21037/apm-21-1718. Epub 2021 Oct 08.

BACKGROUND: For cancer patients nearing death, the prediction of their prognosis by physicians is crucial. This study examined the usefulness of the 1-Day Surprise Question (1DSQ).METHODS: This study was conducted as part of a multicenter prospective observational study. The...

Cite
Ikari T, Hiratsuka Y, Yamaguchi T, et al. Is the 1-day surprise question a useful screening tool for predicting prognosis in patients with advanced cancer?-a multicenter prospective observational study. Ann Palliat Med. 2021;10(11):11278-11287doi: 10.21037/apm-21-1718.
Ikari, T., Hiratsuka, Y., Yamaguchi, T., Mori, M., Uneno, Y., Taniyama, T., Matsuda, Y., Oya, K., Amano, K., Tagami, K., & Inoue, A. (2021). Is the 1-day surprise question a useful screening tool for predicting prognosis in patients with advanced cancer?-a multicenter prospective observational study. Annals of palliative medicine, 10(11), 11278-11287. https://doi.org/10.21037/apm-21-1718
Ikari, Tomoo, et al. "Is the 1-day surprise question a useful screening tool for predicting prognosis in patients with advanced cancer?-a multicenter prospective observational study." Annals of palliative medicine vol. 10,11 (2021): 11278-11287. doi: https://doi.org/10.21037/apm-21-1718
Ikari T, Hiratsuka Y, Yamaguchi T, Mori M, Uneno Y, Taniyama T, Matsuda Y, Oya K, Amano K, Tagami K, Inoue A. Is the 1-day surprise question a useful screening tool for predicting prognosis in patients with advanced cancer?-a multicenter prospective observational study. Ann Palliat Med. 2021 Nov;10(11):11278-11287. doi: 10.21037/apm-21-1718. Epub 2021 Oct 08. PMID: 34670389.
Copy Download .nbib Format: NLM
Showing 589 to 594 of 594 entries